Clinicus Vilnius - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 593,326 | 961,097 | 1,075,656 | 1,586,026 | 1,841,685 | 2,332,778 | 2,341,701 | 2,500,412 |
| Profit before tax | 324,021 | 431,927 | 593,044 | 928,438 | 942,402 | 961,213 | 1,478,226 | 1,555,305 |
| Net profit | 275,124 | 367,073 | 502,870 | 789,262 | 800,947 | 816,088 | 1,258,202 | 1,325,865 |
| Equity | 663,176 | 1,030,249 | 1,206,242 | 1,995,302 | 2,796,248 | 3,524,505 | 4,816,795 | 5,882,998 |
| Liabilities | 48,859 | 52,825 | 71,759 | 151,899 | 63,785 | 188,599 | 162,062 | 211,713 |
| Non-current assets | 119,581 | 171,812 | 123,319 | 246,755 | 741,499 | 1,071,138 | 2,822,199 | 4,473,780 |
| Current assets | 592,454 | 908,816 | 1,154,682 | 1,898,466 | 2,118,534 | 2,641,966 | 2,151,391 | 1,623,178 |
| Total assets | 712,035 | 1,080,628 | 1,278,001 | 2,145,221 | 2,860,033 | 3,713,104 | 4,973,590 | 6,096,958 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 520,325 | 478,111 | 585,704 |
| Social insurance contributions | - | - | - | - | - | 70,339 | 75,127 | 84,354 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +9.0% | +62.0% | +11.9% | +47.4% | +16.1% | +26.7% | +0.4% | +6.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 38.6% | 34.0% | 39.3% | 36.8% | 28.0% | 22.0% | 25.3% | 21.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 41.5% | 35.6% | 41.7% | 39.6% | 28.6% | 23.2% | 26.1% | 22.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 46.4% | 38.2% | 46.8% | 49.8% | 43.5% | 35.0% | 53.7% | 53.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 54.6% | 44.9% | 55.1% | 58.5% | 51.2% | 41.2% | 63.1% | 62.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 296,663 | 480,549 | 496,449 | 366,009 | 140,766 | 100,695 | 99,295 | 98,055 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Clinicus Vilnius - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-08-19 | 2024-08-20 | 6117.79 |
| 2022-05-17 | 2022-05-18 | 0.13 |
| 2022-04-28 | 2022-05-02 | 0.13 |
| 2022-02-17 | 2022-02-20 | 106.86 |
| 2022-01-31 | 2022-02-01 | 0.11 |
| 2021-11-16 | 2021-11-17 | 0.12 |
| 2021-10-18 | 2021-10-19 | 75.78 |
| 2021-09-16 | 2021-09-19 | 81.35 |
Clinicus Vilnius - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Clinicus Vilnius, UAB (code 304089519) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €2.50M, up 6.8% year on year and 7.2% over two years. Net profit increased to €1.33M, after €1.26M in 2024 and €816.1K in 2023, showing a steady improvement in earnings over the 2023–2025 period. The 2025 profit margin remained very strong at 53.0%, close to 53.7% in 2024 and well above 35.0% in 2023. Balance sheet strength also improved: total assets rose to €6.10M in 2025 from €4.97M in 2024 and €3.71M in 2023, while equity increased to €5.88M. Liabilities stayed low at €211.7K, resulting in an equity ratio of 96.5% and debt-to-equity of 0.04. Return on equity was 22.5% and return on assets 21.8% in 2025. Revenue per employee was €100.0K, with profit per employee of €53.0K, indicating solid productivity.